Actions - Biotech
Retour à Hiérarchie Stratégique – Actions & OPCVM
Rang Tech. | Actions | Cours | Synthèse Technique | Momentums | Accé- léra- tion | Tac- tique | ROBO Analyse | Secteurs | PER (X) | Rendt (%) | Croiss. BPA | Croiss. CFA | Croiss. BKV | Croiss. Ventes | Marge Nette | Rentab. Cap.Inv | Dettes ebitda | Tickers | Capi. | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Absolu | Relatif | |||||||||||||||||||
62 | Swed. Orphan Bio | 286.6 | ++++ | ++++ | ++ | Neutre | Biotech | 26.2 X | 0.0% | ++ | +++ | + | ++++ | +++ | - | - | SOBI | MID | ||
57 | Taux = + 20% | +++ | +++++ | |||||||||||||||||
53 | Pluvalca Health Opport. A | 115.2 | +++ | +++++ | Neutre | Neutre | ||||||||||||||
48 | Taux = + 15% | +++ | +++++ | |||||||||||||||||
12 | Tx ESTER j/j rate | + | ++ | |||||||||||||||||
0 | Taux ZERO | Neutre | Neutre | |||||||||||||||||
-5 | Genmab A/S | 2 029 | Neutre | Neutre | - - - | Neutre | Biotech | 30.0 X | 0.0% | + | +++++ | +++++ | ++++ | +++++ | GMA | BIG | ||||
-17 | Franklin Biotech Discovery A | 40.60 | - | Neutre | - - - | - | ||||||||||||||
-18 | Candriam Eqties. L Biotech C | 828.2 | - | - | - - - | Neutre | ||||||||||||||
-49 | Taux = - 5% | - - - | - - | |||||||||||||||||
-75 | CS L Digital Health Eqt. B | 603.3 | - - - - | - - - - | - - - - - | Neutre |